Back to Search
Start Over
Peptide-Based Therapy in Lupus: Promising Data.
- Source :
- Immune-Mediated Diseases; 2007, p106-112, 7p
- Publication Year :
- 2007
-
Abstract
- Systemic lupus erythematosus (SLE) is a multisystem chronic inflammatory disease of multifactorial aetiology, characterized by inflammation and damage of various tissues and organs. Current treatments of the disease are mainly based on immunosuppressive drugs such as corticosteroids and cyclophosphamide. Although these treatments have reduced mortality and morbidity, they cause a non-specific immune suppression. To avoid these side effects, our efforts should focus on the development of alternative therapeutic strategies, which consist, for example in specific T cell targeting using autoantigen-derived peptides identified as sequences encompassing major epitopes. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISBNs :
- 9780387720043
- Database :
- Supplemental Index
- Journal :
- Immune-Mediated Diseases
- Publication Type :
- Book
- Accession number :
- 33169074
- Full Text :
- https://doi.org/10.1007/978-0-387-72005-0_11